Difference between revisions of "Template:Lipid modifying agents"
Jump to navigation
Jump to search
imported>Whywhenwhohow (Bempedoic acid/ezetimibe was approved) |
imported>Whywhenwhohow (add Choline fenofibrate) |
||
| Line 67: | Line 67: | ||
* [[Aluminium clofibrate]] | * [[Aluminium clofibrate]] | ||
* [[Bezafibrate]] | * [[Bezafibrate]] | ||
| + | * [[Choline fenofibrate]] | ||
* [[Ciprofibrate]] | * [[Ciprofibrate]] | ||
* [[Clinofibrate]] | * [[Clinofibrate]] | ||
Revision as of 05:28, 6 March 2020
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Lipid modifying agents|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Lipid modifying agents|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Lipid modifying agents|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.